No headlines found.
No press releases found.
No news found.
Drugs Made In America Acquisition Corp. - Rights trades on the stock market under the symbol DMAAR.
As of December 22, 2025, DMAAR stock price climbed to $0.18 with 2,950 million shares trading.
DMAAR has a beta of -0.57, meaning it tends to be less sensitive to market movements. DMAAR has a correlation of 0.02 to the broad based SPY ETF.
DMAAR has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
DMAAR support price is $.15 and resistance is $.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DMAAR shares will trade within this expected range on the day.
